111 related articles for article (PubMed ID: 36854506)
1. Isophysalin A Inhibits the Stemness of Breast Cancer Cells Possibly
Ko YC; Choi HS; Kim SL; Lee DS
Anticancer Res; 2023 Mar; 43(3):1091-1101. PubMed ID: 36854506
[TBL] [Abstract][Full Text] [Related]
2. BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells.
Kim SL; Choi HS; Lee DS
Cell Commun Signal; 2023 Nov; 21(1):315. PubMed ID: 37924094
[TBL] [Abstract][Full Text] [Related]
3. 5-Desmethylsinensetin isolated from Artemisia princeps suppresses the stemness of breast cancer cells via Stat3/IL-6 and Stat3/YAP1 signaling.
Liu R; Choi HS; Ko YC; Yun BS; Lee DS
Life Sci; 2021 Sep; 280():119729. PubMed ID: 34146553
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
[TBL] [Abstract][Full Text] [Related]
5. 13-Oxo-9Z,11E-octadecadienoic Acid Down-regulates c-Myc and Attenuates Breast Cancer Cell Stemness.
Ko YC; Choi HS; Kim SL; Lee DS
In Vivo; 2023; 37(3):1085-1092. PubMed ID: 37103085
[TBL] [Abstract][Full Text] [Related]
6. Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.
Liu C; Dong L; Sun Z; Wang L; Wang Q; Li H; Zhang J; Wang X
Phytother Res; 2018 Nov; 32(11):2299-2311. PubMed ID: 30080291
[TBL] [Abstract][Full Text] [Related]
7. Betavulgarin Isolated from Sugar Beet (
Liu R; Choi HS; Zhen X; Kim SL; Kim JH; Ko YC; Yun BS; Lee DS
Molecules; 2020 Jun; 25(13):. PubMed ID: 32630026
[TBL] [Abstract][Full Text] [Related]
8. Catechol derived from aronia juice through lactic acid bacteria fermentation inhibits breast cancer stem cell formation via modulation Stat3/IL-6 signaling pathway.
Choi HS; Kim JH; Kim SL; Deng HY; Lee D; Kim CS; Yun BS; Lee DS
Mol Carcinog; 2018 Nov; 57(11):1467-1479. PubMed ID: 29964299
[TBL] [Abstract][Full Text] [Related]
9. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effects of Tangeretin, A Citrus Peel-Derived Flavonoid, on Breast Cancer Stem Cell Formation through Suppression of Stat3 Signaling.
Ko YC; Choi HS; Liu R; Kim JH; Kim SL; Yun BS; Lee DS
Molecules; 2020 Jun; 25(11):. PubMed ID: 32503228
[TBL] [Abstract][Full Text] [Related]
11. Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway.
Kim SL; Choi HS; Kim JH; Jeong DK; Kim KS; Lee DS
Oxid Med Cell Longev; 2019; 2019():9296439. PubMed ID: 31019654
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.
Lin L; Hutzen B; Lee HF; Peng Z; Wang W; Zhao C; Lin HJ; Sun D; Li PK; Li C; Korkaya H; Wicha MS; Lin J
PLoS One; 2013; 8(12):e82821. PubMed ID: 24376586
[TBL] [Abstract][Full Text] [Related]
13. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
[TBL] [Abstract][Full Text] [Related]
14. Anti-Breast Cancer Activities of Ketoprofen-RGD Conjugate by Targeting Breast Cancer Stem-Like Cells and Parental Cells.
Noori S; Rajabi S; Tavirani MR; Shokri B; Zarghi A
Anticancer Agents Med Chem; 2021; 21(8):1027-1036. PubMed ID: 32900351
[TBL] [Abstract][Full Text] [Related]
15. Isoharringtonine inhibits breast cancer stem-like properties and STAT3 signaling.
Chen W; Wang H; Cheng M; Ni L; Zou L; Yang Q; Cai X; Jiao B
Biomed Pharmacother; 2018 Jul; 103():435-442. PubMed ID: 29679903
[TBL] [Abstract][Full Text] [Related]
16. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
[TBL] [Abstract][Full Text] [Related]
17. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
[TBL] [Abstract][Full Text] [Related]
18. STAT3 as a promising chemoresistance biomarker associated with the CD44
Moreira MP; da Conceição Braga L; Cassali GD; Silva LM
Exp Cell Res; 2018 Feb; 363(2):283-290. PubMed ID: 29352988
[TBL] [Abstract][Full Text] [Related]
19. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy.
Rahmati M; Johari B; Kadivar M; Rismani E; Mortazavi Y
J Cell Physiol; 2020 Jun; 235(6):5429-5444. PubMed ID: 31912904
[TBL] [Abstract][Full Text] [Related]
20. Oct4 suppresses IR‑induced premature senescence in breast cancer cells through STAT3- and NF‑κB-mediated IL‑24 production.
Kim JY; Kim JC; Lee JY; Park MJ
Int J Oncol; 2018 Jul; 53(1):47-58. PubMed ID: 29749438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
